TP53 and glioma: It is worth mentioning that increased gain‐of‐function mutation of TP53 in glioma promoted antitumor inflammation, but deteriorated prognostic outcomes in patients with GBM either because inflammation can accelerate the process of GBM or strengthen treatment resistance.50